The US Meals and Drug Administration (FDA) has granted 510(ok) clearance for the Johnson & Johnson (J&J) Medical Units Corporations unit DePuy Synthes’ VELYS Robotic-Assisted Answer to be used with the ATTUNE Whole Knee System.
The answer is designed from know-how developed by Orthotaxy, an organization J&J Medical Units Corporations acquired in 2018.
The table-mounted answer could be built-in into any working room (OR). It adapts to the surgeon’s workflow and might provide them the management they’re accustomed to and perform exact bony cuts.
Utilizing progressive planning capabilities, proprietary know-how, and superior design, the VELYS Robotic-Assisted Answer may also help surgeons to resect bones that align and place the implant relative to the delicate tissue throughout whole knee alternative with out requiring pre-operative imaging.
Moreover, it streamlines knee alternative surgical procedure by providing worthwhile insights, versatile execution, and verified efficiency.
The corporate famous that the answer works with the ATTUNE Whole Knee, which might improve patient-reported outcomes by working in coordination with the anatomy of the affected person to supply stability and movement, utilizing proprietary applied sciences.
The answer can be included in VELYS Digital Surgical procedure Platform of related applied sciences.
DePuy Synthes Franchise firm group chairman Aldo Denti stated: “Coupled with the ATTUNE Whole Knee, the VELYS Robotic-Assisted Answer is very differentiated and may also help enhance medical outcomes and enhance affected person satisfaction, offering a extra enticing medical answer to present choices in the marketplace.
“With the addition of the VELYS Robotic-Assisted Solution to our VELYS Digital Surgery Platform, we are continuing our vision to be the most personalised and connected orthopaedics company.”
In September 2019, DePuy Synthes Merchandise introduced the acquisition of the property of JointPoint to boost surgical accuracy and reproducibility in hip alternative.
